デフォルト表紙
市場調査レポート
商品コード
1556231

血液の世界市場レポート 2024年

Blood Global Market Report 2024


出版日
ページ情報
英文 175 Pages
納期
2~10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
血液の世界市場レポート 2024年
出版日: 2024年09月17日
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

血液の市場規模は、今後数年間で力強い成長が見込まれます。2028年には106億2,000万米ドルに成長し、CAGRは6.3%となります。予測期間中の成長の背景には、政府による支援規制、高齢化人口の増加、血液献体に関する意識の高まり、血液輸血の増加、外来手術センター(ASC)の増加などがあります。この期間の主な動向には、血液輸血およびスクリーニング機器の進歩、コンピュータ化された免疫測定、血液バンクのスマート在庫管理システム、技術革新、正確な温度モニタリングおよび制御などが含まれます。

手術件数の増加が予想され、血液市場の成長を後押しすると予測されています。この増加の背景には、医療技術の進歩、高齢化、慢性疾患の罹患率の増加があります。血液は、酸素や栄養素の供給、出血を抑えるための血液凝固の補助、感染症と闘うための免疫反応の強化など、手術において重要な役割を果たしています。例えば、2023年12月、オーストラリア保健福祉研究所(Australian Institute of Health and Welfare)は、2022年から2023年にかけて、公立病院の選択手術待機リストから735,500人の患者が手術のために入院し、2021年から2022年にかけて18%増加したと報告しました。したがって、手術の急増が血液市場の成長を牽引しています。

血液市場の主なプレーヤーは、効率を高め、ドナーの安全性を向上させ、血液製品の全体的な品質を高めるために、血漿採取システムなどの先進的な血液輸血技術の開拓に注力しています。血漿採取システムは、ドナーの血液から血漿を抽出し、他の成分から分離し、残りの成分をプラズマフェレーシスによってドナーに戻します。例えば、2022年3月、テルモ血液と血液成分と細胞技術を専門とする米国Cell Technologies社は、Rika Plasma Donation System(Rika)の食品医薬品局の承認を取得しました。この次世代血漿採取システムは、血漿センターのスタッフとドナーの経験を向上させることを目的としており、オペレーターのミスを最小限に抑え、35分以内に血漿採取を完了させるための安全性強化を特徴としています。Rikaは、ドナーの体外に常に200ミリリットル以上の血液が出ないようにし、オペレーターのための高度な制御システムを備えています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界の市場規模と成長

  • 世界の血液市場:促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の血液市場の実績:規模と成長, 2018-2023
  • 世界の血液市場の予測:規模と成長, 2023-2028, 2033F

第6章 市場セグメンテーション

  • 世界の血液市場:製品別、実績と予測, 2018-2023, 2023-2028F, 2033F
  • 血液全体の収集と処理
  • 原料血漿収集
  • 血液タイピング製品
  • 血液スクリーニング製品
  • 世界の血液市場:デリバリー方法別、実績と予測, 2018-2023, 2023-2028F, 2033F
  • 輸液ソリューション
  • ジェル
  • スプレー
  • バイオメディカルシーラント
  • 世界の血液市場:エンドユーザー別、実績と予測, 2018-2023, 2023-2028F, 2033F
  • 血液および血液コンポーネントバンク
  • 診断検査室
  • 外来手術センター
  • 病院
  • その他のエンドユーザー

第7章 地域別・国別分析

  • 世界の血液市場:地域別、実績と予測, 2018-2023, 2023-2028F, 2033F
  • 世界の血液市場:国別、実績と予測, 2018-2023, 2023-2028F, 2033F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 血液市場:競合情勢
  • 血液市場:企業プロファイル
    • Cardinal Health Inc.
    • Roche Holding AG
    • Thermo Fisher Scientific Inc.
    • Abbott Laboratories
    • Medtronic Plc

第31章 その他の大手企業と革新的企業

  • Danaher Corp.
  • Merck KGaA
  • Asahi Kasei Medical Co. Ltd.
  • Henry Schein Inc.
  • Medline Industries Inc.
  • B. Braun Melsungen AG
  • Grifols SA
  • Terumo Corp.
  • Nipro Corp.
  • QuidelOrtho Corp.
  • Bio Rad Laboratories Inc.
  • LivaNova PLC
  • Haemonetics Corp.
  • Macopharma
  • DIAGAST SAS

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと潜在的な分析

第36章 付録

目次
Product Code: r19579

Blood is a crucial bodily fluid essential for the proper functioning of organs. It is a complex mixture of components, including red blood cells, white blood cells, platelets, and plasma, which are vital for maintaining health and facilitating medical treatments.

The primary blood-related products include whole blood collection and processing, source plasma collection, blood typing products, and blood screening products. Whole blood collection and processing involves the collection, separation, and storage of whole blood, which encompasses red blood cells, white blood cells, platelets, and plasma. Various modes of delivery include infusion solutions, gels, sprays, and biomedical sealants. These products are utilized by a range of end users, such as blood and blood component banks, diagnostic laboratories, ambulatory surgical centers, hospitals, and others.

The blood market research report is one of a series of new reports from The Business Research Company that provides blood market statistics, including blood industry global market size, regional shares, competitors with a blood market share, detailed blood market segments, market trends and opportunities, and any further data you may need to thrive in the blood industry. This blood market research report delivers a complete perspective on everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The blood market size has grown strongly in recent years. It will grow from $7.83 billion in 2023 to $8.32 billion in 2024 at a compound annual growth rate (CAGR) of 6.2%. The historic growth can be attributed to the rising demand for blood and plasma, an increase in surgical procedures, a growing global population, higher incidence of chronic diseases, and a greater number of blood banks.

The blood market size is expected to see strong growth in the next few years. It will grow to $10.62 billion in 2028 at a compound annual growth rate (CAGR) of 6.3%. The growth during the forecast period can be attributed to supportive government regulations, an increase in the aging population, growing awareness about blood donation, a rise in blood transfusions, and a higher number of ambulatory surgical centers (ASCs). Key trends in this period include advancements in blood transfusion and screening instruments, computerized immunoassays, smart inventory control systems for blood banks, technological innovations, and precise temperature monitoring and control.

The anticipated rise in the number of surgeries is projected to boost the growth of the blood market. This increase is attributed to advancements in medical technology, an aging population, and a higher incidence of chronic diseases. Blood plays a critical role in surgeries by delivering oxygen and nutrients, aiding clotting to control bleeding, and enhancing the immune response to fight infections. For example, in December 2023, the Australian Institute of Health and Welfare reported that in 2022-2023, 735,500 patients were admitted for surgery from public hospital elective surgery waiting lists, an 18% increase from 2021-2022. Hence, the surge in surgeries is driving growth in the blood market.

Key players in the blood market are focusing on developing advanced blood transfusion technologies, such as plasma collection systems, to enhance efficiency, improve donor safety, and boost the overall quality of blood products. A plasma collection system extracts plasma from a donor's blood by separating it from other components and returning the remaining components to the donor through plasmapheresis. For instance, in March 2022, Terumo Blood and Cell Technologies, a US-based company specializing in blood components and cellular technology, received Food and Drug Administration approval for the Rika Plasma Donation System (Rika). This next-generation plasma collection system aims to enhance the experience for plasma center staff and donors, featuring safety enhancements to minimize operator errors and complete plasma collection in 35 minutes or less. Rika ensures that no more than 200 milliliters of blood are outside the donor's body at any time and includes an advanced control system for operators.

In March 2023, Werfen, a Spain-based medical equipment manufacturer, acquired Immucor Inc. for $2 billion. This acquisition is intended to broaden Werfen's diagnostic solutions portfolio, particularly in specialized diagnostics, allowing it to offer a more comprehensive range of products to customers, including hospitals, blood banks, and clinical laboratories. Immucor Inc., a US-based company, develops, manufactures, and markets products used by hospitals, blood banks, and clinical laboratories to detect and identify blood properties prior to transfusion.

Major companies operating in the blood market are Cardinal Health Inc., Roche Holding AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Medtronic Plc, Danaher Corp., Merck KGaA, Asahi Kasei Medical Co. Ltd., Henry Schein Inc., Medline Industries Inc., B. Braun Melsungen AG, Grifols SA, Terumo Corp., Nipro Corp., QuidelOrtho Corp., Bio Rad Laboratories Inc., LivaNova PLC, Haemonetics Corp., Macopharma, DIAGAST SAS, BAG Health Care GmbH, Kawasumi Laboratories America Inc

North America was the largest region in the blood market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the blood market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the blood market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The blood market consists of sales of blood bags, blood glucose analyzers, blood collection tubes, and blood transfusion sets. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Blood Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on blood market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for blood ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The blood market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Whole Blood Collection And Processing; Source Plasma Collection; Blood Typing Products; Blood Screening Products
  • 2) By Mode of Delivery: Infusion Solutions; Gels; Sprays; Biomedical Sealants
  • 3) By End User: Blood And Blood Component Bank; Diagnostic Laboratories; Ambulatory Surgical Centers; Hospitals; Other End Users
  • Companies Mentioned: Cardinal Health Inc.; Roche Holding AG; Thermo Fisher Scientific Inc.; Abbott Laboratories; Medtronic Plc
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Blood Market Characteristics

3. Blood Market Trends And Strategies

4. Blood Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Blood Market Size and Growth

  • 5.1. Global Blood Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Blood Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Blood Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Blood Market Segmentation

  • 6.1. Global Blood Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Whole Blood Collection And Processing
  • Source Plasma Collection
  • Blood Typing Products
  • Blood Screening Products
  • 6.2. Global Blood Market, Segmentation By Mode of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Infusion Solutions
  • Gels
  • Sprays
  • Biomedical Sealants
  • 6.3. Global Blood Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Blood And Blood Component Bank
  • Diagnostic Laboratories
  • Ambulatory Surgical Centers
  • Hospitals
  • Other End Users

7. Blood Market Regional And Country Analysis

  • 7.1. Global Blood Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Blood Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Blood Market

  • 8.1. Asia-Pacific Blood Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Blood Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Blood Market, Segmentation By Mode of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Blood Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Blood Market

  • 9.1. China Blood Market Overview
  • 9.2. China Blood Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Blood Market, Segmentation By Mode of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Blood Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Blood Market

  • 10.1. India Blood Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Blood Market, Segmentation By Mode of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Blood Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Blood Market

  • 11.1. Japan Blood Market Overview
  • 11.2. Japan Blood Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Blood Market, Segmentation By Mode of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Blood Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Blood Market

  • 12.1. Australia Blood Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Blood Market, Segmentation By Mode of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Blood Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Blood Market

  • 13.1. Indonesia Blood Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Blood Market, Segmentation By Mode of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Blood Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Blood Market

  • 14.1. South Korea Blood Market Overview
  • 14.2. South Korea Blood Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Blood Market, Segmentation By Mode of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Blood Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Blood Market

  • 15.1. Western Europe Blood Market Overview
  • 15.2. Western Europe Blood Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Blood Market, Segmentation By Mode of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Blood Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Blood Market

  • 16.1. UK Blood Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Blood Market, Segmentation By Mode of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Blood Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Blood Market

  • 17.1. Germany Blood Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Blood Market, Segmentation By Mode of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Blood Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Blood Market

  • 18.1. France Blood Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Blood Market, Segmentation By Mode of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Blood Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Blood Market

  • 19.1. Italy Blood Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Blood Market, Segmentation By Mode of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Blood Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Blood Market

  • 20.1. Spain Blood Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Blood Market, Segmentation By Mode of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Blood Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Blood Market

  • 21.1. Eastern Europe Blood Market Overview
  • 21.2. Eastern Europe Blood Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Blood Market, Segmentation By Mode of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Blood Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Blood Market

  • 22.1. Russia Blood Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Blood Market, Segmentation By Mode of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Blood Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Blood Market

  • 23.1. North America Blood Market Overview
  • 23.2. North America Blood Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Blood Market, Segmentation By Mode of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Blood Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Blood Market

  • 24.1. USA Blood Market Overview
  • 24.2. USA Blood Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Blood Market, Segmentation By Mode of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Blood Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Blood Market

  • 25.1. Canada Blood Market Overview
  • 25.2. Canada Blood Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Blood Market, Segmentation By Mode of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Blood Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Blood Market

  • 26.1. South America Blood Market Overview
  • 26.2. South America Blood Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Blood Market, Segmentation By Mode of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Blood Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Blood Market

  • 27.1. Brazil Blood Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Blood Market, Segmentation By Mode of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Blood Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Blood Market

  • 28.1. Middle East Blood Market Overview
  • 28.2. Middle East Blood Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Blood Market, Segmentation By Mode of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Blood Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Blood Market

  • 29.1. Africa Blood Market Overview
  • 29.2. Africa Blood Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Blood Market, Segmentation By Mode of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Blood Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Blood Market Competitive Landscape And Company Profiles

  • 30.1. Blood Market Competitive Landscape
  • 30.2. Blood Market Company Profiles
    • 30.2.1. Cardinal Health Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Roche Holding AG
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Thermo Fisher Scientific Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Abbott Laboratories
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Medtronic Plc
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Blood Market Other Major And Innovative Companies

  • 31.1. Danaher Corp.
  • 31.2. Merck KGaA
  • 31.3. Asahi Kasei Medical Co. Ltd.
  • 31.4. Henry Schein Inc.
  • 31.5. Medline Industries Inc.
  • 31.6. B. Braun Melsungen AG
  • 31.7. Grifols SA
  • 31.8. Terumo Corp.
  • 31.9. Nipro Corp.
  • 31.10. QuidelOrtho Corp.
  • 31.11. Bio Rad Laboratories Inc.
  • 31.12. LivaNova PLC
  • 31.13. Haemonetics Corp.
  • 31.14. Macopharma
  • 31.15. DIAGAST SAS

32. Global Blood Market Competitive Benchmarking

33. Global Blood Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Blood Market

35. Blood Market Future Outlook and Potential Analysis

  • 35.1 Blood Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Blood Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Blood Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer